1. Home
  2. INFU vs AVXL Comparison

INFU vs AVXL Comparison

Compare INFU & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InfuSystems Holdings Inc.

INFU

InfuSystems Holdings Inc.

SELL

Current Price

$13.64

Market Cap

270.1M

Sector

Health Care

ML Signal

SELL

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$1.51

Market Cap

237.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INFU
AVXL
Founded
2005
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
270.1M
237.2M
IPO Year
2005
2013

Fundamental Metrics

Financial Performance
Metric
INFU
AVXL
Price
$13.64
$1.51
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $16.83
N/A
AVG Volume (30 Days)
124.0K
★ 1.1M
Earning Date
11-03-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 181.82
N/A
EPS
★ 0.20
N/A
Revenue
★ $143,436,000.00
N/A
Revenue This Year
$1.20
N/A
Revenue Next Year
$6.16
N/A
P/E Ratio
$68.00
★ N/A
Revenue Growth
★ 6.36
N/A
52 Week Low
$7.29
$1.44
52 Week High
$13.85
$9.50

Technical Indicators

Market Signals
Indicator
INFU
AVXL
Relative Strength Index (RSI) 67.91 20.06
Support Level $8.77 N/A
Resistance Level $13.85 $2.80
Average True Range (ATR) 0.40 0.13
MACD 0.01 -0.03
Stochastic Oscillator 83.38 6.06

Price Performance

Historical Comparison
INFU
AVXL

About INFU InfuSystems Holdings Inc.

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: